Putnam Investments’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-29,501
| Closed | -$330K | – | 1179 |
|
|
2023
Q3 | $330K | Sell |
29,501
-255
| -0.9% | -$2.85K | ﹤0.01% | 1051 |
|
|
2023
Q2 | $637K | Sell |
29,756
-929
| -3% | -$19.9K | ﹤0.01% | 891 |
|
|
2023
Q1 | $1.24M | Sell |
30,685
-1,299
| -4% | -$52.5K | ﹤0.01% | 830 |
|
|
2022
Q4 | $1.49M | Sell |
31,984
-18
| -0.1% | -$837 | ﹤0.01% | 775 |
|
|
2022
Q3 | $1.66M | Sell |
32,002
-11,001
| -26% | -$571K | ﹤0.01% | 778 |
|
|
2022
Q2 | $2.03M | Buy |
43,003
+16,293
| +61% | +$770K | ﹤0.01% | 728 |
|
|
2022
Q1 | $1.9M | Sell |
26,710
-2,026
| -7% | -$144K | ﹤0.01% | 807 |
|
|
2021
Q4 | $2.15M | Buy |
+28,736
| New | +$2.15M | ﹤0.01% | 752 |
|
|
2015
Q4 | – | Sell |
-42,278
| Closed | -$1.53M | – | 1456 |
|
|
2015
Q3 | $1.53M | Buy |
42,278
+1,087
| +3% | +$39.3K | ﹤0.01% | 1066 |
|
|
2015
Q2 | $1.85M | Buy |
41,191
+15,798
| +62% | +$711K | ﹤0.01% | 1086 |
|
|
2015
Q1 | $777K | Sell |
25,393
-891
| -3% | -$27.3K | ﹤0.01% | 1242 |
|
|
2014
Q4 | $1.34M | Sell |
26,284
-143
| -0.5% | -$7.27K | ﹤0.01% | 1139 |
|
|
2014
Q3 | $1.05M | Buy |
26,427
+466
| +2% | +$18.4K | ﹤0.01% | 1193 |
|
|
2014
Q2 | $1.12M | Buy |
25,961
+32
| +0.1% | +$1.38K | ﹤0.01% | 1167 |
|
|
2014
Q1 | $1.04M | Buy |
+25,929
| New | +$1.04M | ﹤0.01% | 1190 |
|